Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 1/2011

01-01-2011 | Research Articles

The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients

Authors: Juan Ignacio Arraras, Javier Suárez, Fernando Arias de la Vega, Ruth Vera, Gemma Asín, Virginia Arrazubi, Mikel Rico, Lucía Teijeira, Jaione Azparren

Published in: Clinical and Translational Oncology | Issue 1/2011

Login to get access
Metadata
Title
The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients
Authors
Juan Ignacio Arraras
Javier Suárez
Fernando Arias de la Vega
Ruth Vera
Gemma Asín
Virginia Arrazubi
Mikel Rico
Lucía Teijeira
Jaione Azparren
Publication date
01-01-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 1/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0616-y

Other articles of this Issue 1/2011

Clinical and Translational Oncology 1/2011 Go to the issue

Research Articles

In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines

Educational Series

Electrochemotherapy for treatment of skin and soft tissue tumours. Update and definition of its role in multimodal therapy

Research Articles

Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer

Educational Series

Gallbladder carcinoma incidentally encountered during laparoscopic cholecystectomy: how to deal with it

Educational Series

Using living cells to transport therapeutic genes for cancer treatment

Editorial

Basic and discovery-based translational research on cancer was on the agenda at the 21st Congress of the European Association for Cancer Research (EACR) in Oslo, Norway, 26–29 June 2010
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits